UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D/A

(Amendment No. 1)

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

RULE 13d-2(a)

 

SHL TELEMEDICINE LTD.

(Name of Issuer)

 

American Depositary Shares, each representing one ordinary share, par value NIS 0.01 per share

(Title of Class of Securities)

 

78423T200

(CUSIP Number)

 

Ilana Freundlich

94 Yigal Alon Street, Tel Aviv 6789155, Israel

+972-3-5611152

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

February 8, 2024

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), (f) or (g), check the following box: ☐

 

Note: Schedules filed in paper format should include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

  * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

CUSIP No. 78423T200     Page 2 of 7

 

1

NAME OR REPORTING PERSON

 

Danbar Finance Ltd.(1)

 
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☒

(b) ☐

3

SEC USE ONLY

 

 
4

SOURCE OF FUNDS 

 

PF

 
5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION:

 

State of Israel

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7

SOLE VOTING POWER

 

791,405

8

SHARED VOTING POWER

 

0

9

SOLE DISPOSITIVE POWER

 

791,405

10

SHARED DISPOSITIVE POWER

 

0

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

 

791,405

 
12

CHECK IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

4.8%(2)

 
14

TYPE OF REPORTING PERSON

 

CO

 

 

(1) Matan Wulkan and Nir Rotenberg are the shareholders of Danbar Finance Ltd. (“Danbar”). Mr. Wulkan and Mr. Rotenberg are the sole directors of Danbar. Mr. Rotenberg was elected as a director of SHL Telemedicine Ltd. (the “Issuer”) upon approval of the Issuer’s shareholders at the Issuer’s annual general meeting of shareholders on February 8, 2024. Danbar, Mr. Wulkan and Mr. Rotenberg are collectively referred to as the “Reporting Persons”.

(2) Based on 16,392,754 Ordinary Shares outstanding as of December 26, 2023 (as reported in Exhibit 99.1 to the Issuer's Form 6-K filed with the Securities and Exchange Commission (“SEC”) on December 28, 2023).

 

 

 

CUSIP No. 78423T200     Page 3 of 7

 

1

NAME OR REPORTING PERSON

 

Matan Wulkan(1)

 
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☒

(b) ☐

3

SEC USE ONLY

 

 
4

SOURCE OF FUNDS 

 

PF

 
5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION:

 

State of Israel

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7

SOLE VOTING POWER

 

122,727(2)

8

SHARED VOTING POWER

 

791,405

9

SOLE DISPOSITIVE POWER

 

122,727(2)

10

SHARED DISPOSITIVE POWER

 

791,405

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

 

914,132

 
12

CHECK IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

5.6%(3)

 
14

TYPE OF REPORTING PERSON

 

IN

 

 

(1) Matan Wulkan is a director and a shareholder of Danbar.

(2) The 122,727 Ordinary Shares are held of record by Miri Wulkan, Mr. Wulkan’s mother. Mr. Wulkan has sole voting and dispositive power over such Ordinary Shares.

(3) Based on 16,392,754 Ordinary Shares outstanding as of December 26, 2023 (as reported in Exhibit 99.1 to the Issuer's Form 6-K filed with the SEC on December 28, 2023).

 

 

 

CUSIP No. 78423T200     Page 4 of 7

 

1

NAME OR REPORTING PERSON

 

Nir Rotenberg(1)

 
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☒

(b) ☐

3

SEC USE ONLY

 

 
4

SOURCE OF FUNDS 

 

PF

 
5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION:

 

State of Israel

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7

SOLE VOTING POWER

 

27,000

8

SHARED VOTING POWER

 

791,405

9

SOLE DISPOSITIVE POWER

 

27,000

10

SHARED DISPOSITIVE POWER

 

791,405

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

 

818,405

 
12

CHECK IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

5.0%(2)

 
14

TYPE OF REPORTING PERSON

 

IN

 

 

(1) Nir Rotenberg is a director and a shareholder of Danbar.

(2) Based on 16,392,754 Ordinary Shares outstanding as of December 26, 2023 (as reported in Exhibit 99.1 to the Issuer's Form 6-K filed with the SEC on December 28, 2023).

 

 

  

CUSIP No. 78423T200     Page 5 of 7

 

This Amendment No. 1 to Schedule 13D (this “Schedule 13D/A”) amends and supplements the Schedule 13D initially filed with the Securities and Exchange Commission (the “SEC”) on December 26, 2023 by the Reporting Persons named herein.

 

Item 1. Security and Issuer.

 

This item is not being amended by this Schedule 13D/A.

 

Item 2. Identity and Background.

 

This item is not being amended by this Schedule 13D/A.

 

Item 3. Source and Amount of Funds or Other Consideration.

 

This item is not being amended by this Schedule 13D/A.

 

Item 4. Purpose of Transaction.

 

Item 4. “Purpose of Transaction” of the Schedule 13D is hereby amended to add the following;

 

On February 8, 2024, Mr. Rotenberg was elected as a Director of the Issuer upon approval of the Issuer’s shareholders at the Issuer’s annual general meeting of shareholders.

 

 

 

CUSIP No. 78423T200     Page 6 of 7

 

Item 5. Interest in Securities of the Issuer.

 

  (a) (b) Number and percentage of Issuer Ordinary Shares beneficially owned by each Reporting Person:

 

Reporting Person  Number of
Ordinary
Shares
   Percentage
of Class(1)
 
Danbar Finance Ltd.   791,405(2)   4.8%
Matan Wulkan   914,132(3)   5.6%
Nir Rotenberg   818,405(4)   5.0%

 

(1) Based on 16,392,754 Ordinary Shares outstanding as of December 26, 2023 (as reported in Exhibit 99.1 to the Issuer's Form 6-K filed with the SEC on December 28, 2023).

(2) Danbar is deemed to beneficially own 791,405 Ordinary Shares held by it directly.

(3) Mr. Wulkan is deemed to beneficially own 914,132 Ordinary Shares, consisting of: (i) 122,727 Ordinary Shares held of record by Miri Wulkan, Mr. Wulkan’s mother. Mr. Wulkan has sole voting and dispositive power over such Ordinary Shares, and (ii) 791,405 Ordinary Shares held by Danbar, over which Mr. Wulkan shares voting and dispositive power with Mr. Rotenberg.

(4) Mr. Rotenberg is deemed to beneficially own 818,405 Ordinary Shares, consisting of: (i) 27,000 Ordinary Shares held directly, and (ii) 791,405 Ordinary Shares held by Danbar, over which Mr. Rotenberg shares voting and dispositive power with Mr. Wulkan.

 

See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Ordinary Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

 

(c) The table below specifies the date, amount and weighted average per share price of Ordinary Shares purchased by the Reporting Persons in the past sixty days. All transactions reflected in the table below were effected in the open market on the SIX Swiss Exchange:

 

Reporting Person   Trade Date   Number of Ordinary Shares     Avg. Price Per Ordinary Share(1)  
Danbar Finance Ltd.   February 6, 2024     11,934     CHF 5.55  
Danbar Finance Ltd.   February 7, 2024     33,066     CHF 5.66  
Danbar Finance Ltd.   February 8, 2024     19,512     CHF 5.45  
Matan Wulkan   January 11, 2024     3,667     CHF 6.25  
Matan Wulkan   January 15, 2024     3,600     CHF 6.46  
Matan Wulkan   January 17, 2024     1,946     CHF 6.05  
Matan Wulkan   January 18, 2024     3,454     CHF 6.14  
Matan Wulkan   January 19, 2024     3,600     CHF 6.01  
Matan Wulkan   January 22, 2024     3,588     CHF 5.92  
Matan Wulkan   January 23, 2024     7,212     CHF 5.89  
Matan Wulkan   January 24, 2024     3,600     CHF 5.57  
Matan Wulkan   January 26, 2024     1,742     CHF 5.60  
Matan Wulkan   February 2, 2024     7,258     CHF 5.57  
Matan Wulkan   February 5, 2024     5,497     CHF 5.45  
Matan Wulkan   February 6, 2024     1,800     CHF 5.55  
Matan Wulkan   February 8, 2024     230     CHF 5.20  
Nir Rotenberg   January 23, 2024     8,100     CHF 5.90  

 

 

(1) The price reported is the weighted average price in Swiss franc (“CHF”) as of the relevant trade date. The Reporting Persons undertake to provide, upon request by the staff of the SEC, full information regarding the number of Ordinary Shares purchased at each separate price within the ranges set forth in this footnote.

 

(d) No other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities covered by this Schedule 13D.

 

(e) Not applicable.

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

This item is not being amended by this Schedule 13D/A.

 

Item 7. Material to Be Filed as Exhibits.

  

This item is not being amended by this Schedule 13D/A.

 

 

 

CUSIP No. 78423T200     Page 7 of 7

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 14, 2024    
     
  DANBAR FINANCE LTD.
     
  By: /s/ Matan Wulkan 
  Name:  Matan Wulkan
  Title: Director
     
  MATAN WULKAN
     
  /s/ Matan Wulkan 
     
  NIR ROTENBERG
     
  /s/ Nir Rotenberg 

 

 

 

 

 

 


SHL Telemedicine (NASDAQ:SHLT)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more SHL Telemedicine Charts.
SHL Telemedicine (NASDAQ:SHLT)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more SHL Telemedicine Charts.